|
Note: The patented rhGDF-5 is also referred to in the literature under the following names: MP52, BMP-14, CDMP-1
On the following pages, publications can be found that were written by Biopharm and by its partners who were supported by Biopharm.
Here is an overview of current publications:
|
The effect of two point mutations in GDF-5 on ectopic bone formation in a beta-tricalciumphosphate scaffold. Biomaterials, 31(14), 3878-84, 2010, Epub 2010 Feb 18. Kasten P, Beyen I, Bormann D, Luginbühl R, Plöger F, Richter W.
|
|
Rahmenbedingungen und Konzepte für mittelständische Pharmaunternehmen bei der Entwicklung von Biosimilar PharmInd, 72 (4), 224-230, 2010 Dr. Michael Kruse
|
 |
|
GDF5 and BMP2 inhibit apoptosis via activation of BMPR2 and subsequent stabilization of XIAP Biochim Biophys Acta, 1793, 1819-27, 2009 Liu Z, Shen J, Pu K, Katus HA, Plöger F, Tiefenbacher CP, Chen X, Braun T. |
You will find additional publications in our archive, sorted by year.  To the publication archive
|
